Federated Hermes
WHWK

Federated Hermes’s Whitehawk Therapeutics WHWK Stock Holding History

Federated Hermes’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-358
Closed -$669 – 2264
2025
Q2 		$669 Sell
358
-572
-62% -$996 ﹤0.01% 2025
2025
Q1 		$1.66K Sell
930
-3,794
-80% -$9.91K ﹤0.01% 1966
2024
Q4 		$14.9K Sell
4,724
-99
-2% -$224 ﹤0.01% 1798
2024
Q3 		$9.94K Buy
4,823
+529
+12% +$855 ﹤0.01% 1809
2024
Q2 		$6.27K Buy
4,294
+580
+16% +$1.07K ﹤0.01% 1819
2024
Q1 		$8.69K Buy
3,714
+3,259
+716% +$6.28K ﹤0.01% 1793
2023
Q4 		$919 Buy
+455
New +$1.91K ﹤0.01% 1979
2023
Q2 		– Sell
-191
Closed -$1.38K – 2240
2023
Q1 		$1.38K Sell
191
-14,679
-99% -$157K ﹤0.01% 2027
2022
Q4 		$191K Buy
+14,870
New +$194K ﹤0.01% 1566

Other funds holding WHWK

QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

Federated Hermes's WHWK Position: Q3 2025 in Review

Federated Hermes sold out of Whitehawk Therapeutics (WHWK) in Q3 2025, closing a stake of 358 shares — an estimated $669 sold.

Federated Hermes first reported a position in WHWK in Q4 2022 and held it in 9 quarters. The position peaked at $191K in Q4 2022. 41 funds tracked by Wall St. Rank hold WHWK as of Q3 2025.

  • Federated Hermes reported no remaining Whitehawk Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Federated Hermes sold 358 Whitehawk Therapeutics shares in Q3 2025, an estimated $669.
  • Federated Hermes first reported a position in Whitehawk Therapeutics in Q4 2022 and held it in 9 quarters.
  • Federated Hermes's Whitehawk Therapeutics position peaked at $191K in Q4 2022.
  • 41 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2025.

Based on Federated Hermes's 13F filing for Q3 2025, filed 3 Nov 2025.